Zhengye Biotechnology Holding Limited (ZYBT)

Market Cap	39.95M -81.0%
Revenue (ttm)	21.46M -19.0%
Net Income	-2.70M
EPS	-0.06
Shares Out	47.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,302
Open	0.8055
Previous Close	0.8456
Day's Range	0.7700 - 0.8700
52-Week Range	0.6800 - 14.3000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2025

About ZYBT

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 7, 2025
• Employees: 277
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYBT
• Website: https://www.jlzybio.com

Financial Performance

In 2024, ZYBT's revenue was 186.36 million, a decrease of -11.95% compared to the previous year's 211.65 million. Earnings were 11.31 million, a decrease of -64.04%.

Financial numbers in CNY